-P O S T P O N E D- Joint FDA-EMA Seminar

                                   -P O S T P O N E D-
More information to follow when a new date is available.

The Embassy of Denmark in Washington, DC is proud to present for the first time a seminar in collaboration with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This seminar might be quite relevant to DANISH BIO – DANSK BIOTEK members.

The 2-day seminar will be led by FDA and EMA officials and include preliminary topics such as; Innovation, Regenerative Medicines, Precision Medicine, MRA and International Collaboration, Real-World Evidence, Oncology and Tumor Agnostic Development, Breakthrough PRIME, and Patient-Centric Regulatory work.

Why Attend?

• Understand the latest developments and critical changes underway to create successful strategies in the USA & Europe
• Benchmark your regulatory strategies against agency requirements
• Opportunity for brief one-on-one meetings with FDA & EMA officials

Registration fee = 7,000 DKK/person

• Covers 2-day seminar, all materials, lunches and refreshments
• Seating is limited

Join the mailing list using attached form for updates & registration form when released.